NewsInnovative Trials2024-11-25T12:21:32+00:00

IT logotype with strapline_on dark backgrounds 1300x264px

News

Stay updated with the latest news from Innovative Trials

AstraZeneca and Merck decision to disinvest in UK is a ‘tragedy’ for British research and innovation, says Innovative Trials

Phil Long2025-10-09T16:20:55+01:00September 16th, 2025|

The recent decision by pharmaceutical company AstraZeneca to pause a planned £200 million expansion of

Innovative Trials names Hertfordshire hospice as 2025 UK charity partner

Phil Long2025-07-28T11:16:10+01:00June 23rd, 2025|

Innovative Trials, an internationally renowned clinical trials patient recruitment company based in the UK, has today announced Garden

Education urgently needed to reverse lack of women-only clinical trials, says Innovative Trials

Phil Long2025-05-14T11:18:01+01:00May 9th, 2025|

Kate Shaw, founder and CEO of Innovative Trials, has responded to data that shows the UK has far

Innovative Trials appoints first Non-Executive Chair

Phil Long2025-01-20T11:11:26+00:00January 20th, 2025|

John Watkinson is the new Non-Exec Chair as Innovative Trials targets significant business growth Innovative Trials, a specialist

Innovative Trials celebrates success for its groundbreaking Retention Patch Program

Phil Long2024-11-22T09:30:55+00:00November 22nd, 2024|

Innovative Trials celebrates initiative success with industry peers at 2024 PMEA Awards Innovative Trials, a global clinical trial

Innovative Trials named a top UK women-powered company in clinical research by J.P. Morgan

Phil Long2024-10-31T11:44:02+00:00October 28th, 2024|

Innovative Trials is the second fastest-growing, woman-powered UK company in the clinical research sector and in the top

Learn more how we accelerate patient recruitment

Therapy Areas

We have extensive experience of study phases I to IV, adults and paediatrics and both acute and chronic conditions.

Analgesics

Intra Abdominal pain
Post Operative pain

General Medicine

Non Alcoholic Fatty Liver Disease (NAFLD)
Non Alcoholic Steatohepatitis (NASH)
Hypercholesterolaemia
Type II Diabetes

Haematology

Anaemia
Haemophilia
Sickle Cell
Thrombocytopenia

Bone

Osteoarthritis

Dermatology

Atopic Dermatitis
Hidradenitis Suppurativa
Psoriasis

Gastroenterology

Crohn’s Disease
Ulcerative Colitis

Infection

Bacterial infection – Sepsis
C-Diff
Intra-abdominal Infectious Disease
Pneumonia

Immunology

Ankylosing Spondylitis
Alopecia
Asthma
Atopic Dermatitis
Crohn’s Disease
Hidradenitis Suppurativa
Lupus
Nasal Polyps
Psoriasis
Psoriatic Arthritis
Rheumatoid Arthritis
Ulcerative Colitis
Vitiligo

Neuroscience/CNS

Alzheimer’s Disease
Epilepsy
Depression
Duchenne Muscular Dystrophy (DMD)
Dyskinesia in Cerebral Palsy
Migraine
Multiple Sclerosis
Parkinson’s Disease
Schizophrenia

Oncology

Acute Myeloid Leukaemia
Basal Cell Carcinoma
Bladder Cancer
Breast Cancer
Colorectal Cancer
Gastric Cancer
Head & Neck Cancer
Liver Cancer
Lung Cancer
Lymphoma
Metastatic Bone Pain
Myelofibrosis
Mutant Tumours
NSCLC
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer
Solid Tumour
Treatment Resistance Post Cancer Treatment
Urothelial Cancer

Respiratory

Asthma
COPD

Urology

Over-active Bladder

Vaccines

Pneumonia
Urinary Tract Infection

Vascular Disease

Stroke

Women’s Health

Birth Control
Interstitial Cystitis
STD Prevention
Urinary Tract Infection

Do you need to minimise the impact on your clinical trials, or boost patient recruitment in your Covid-19 studies?

Let’s talk

You are one step away from discovering how we can work side by side to support your patient recruitment needs.